Formulating Better Medicines for Children

Monday 2 March
10.30                Registration and coffee
11.00                Introduction to the conference and the EuPFiCatherine Tuleu, University of London and EuPFI, UK 
11.15                EMEA refresherCaroline Le Barbier, EMEA, UK 
12.00                Soap box session
10 minute presentations on successes, concerns, observations and lesson learned on global paediatric dosage form development. Delegates are invited to register their interest to make a presentation.
13.00                Lunch and networking
14.00                Introduction by the Chair 
14.15                Age-appropriate formulations and paediatric investigation plansDaniel Brasseur, Paediatric Committee, EMEA, UK 
14.45                Importance of formulation for the consumerJenny Preston, UK Medicines for Children Research network (consumer liaison group) 
15.00                Clinical pharmaceutics: hospital point of viewAndre Rieutord, Hôpital Antoine BECLERE, France  
15.30                Tea Break
16.00                A Survey of Extemporaneous activities around EuropeMaria Joao-Carvahlo, University of London, UK 
16.30                Swallowing the bitter pill: old & new approaches to tasteScott Siegel, Redpoint Bio Corp, USA
17.00                Experience sharing in global formulation developmentFabrice Mouveaux, Sanofi Aventis, France

17.30-20.00       Networking wine reception    

Tuesday 3 March 2009 
09.00                Roundtable: The Way Forward - ‘E Numbers in Paediatric Formulations: the Good, the Bad or the Ugly'Facilitator: John Hempenstall, GSK and EuPFI
Panel: Tony Nunn, Alder Hey Children's NHS Foundation Trust and NIHR MCRN (Clinical, EuPFI); Daniel Bar-Shalom, IPC International (Industry); Pat Crowley, Callum Consulting, LLC (Consultant); Kalle Hoppu, WHO (Paediatrician). 
10.15                Coffee break 
11.45                Importance of formulation in developing countries: From Challenges to specificationsAtieno Ojoo, UNICEF 
12.15                Close of conference

Catherine Tuleu, University of London and EuPFI, UK